BackJounce Therapeutics Overview

Jounce Therapeutics Gross Profit

Gross Profit analysis for JNCE.

Quarterly Gross Profit

$82.00M
↑ 315384515.38% YoY

As of Dec 31, 2022

Annual Gross Profit (TTM)

$82.00M
↑ 204.75% YoY

Trailing 12 months ending Dec 31, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin